Evaluation of coagulation abnormalities in brain tumors in the perioperative period
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Supratentorial primary brain tumors, undergoing surgery for removal of tumor
- Registration Number
- CTRI/2018/01/011272
- Lead Sponsor
- Dr Manikandan S
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 25
Inclusion Criteria
Surgery for newly diagnosed primary brain tumors in supratentorial area with
tumor size >3 cm
ASA 1,2
GCS 14-15
Exclusion criteria:
Ã? GCS
Exclusion Criteria
GCS <13
ASA 3&4
Recurrent tumors.
Presence of significant co morbidities like diabetes, hypertension, liver disease,
ischemic heart disease, stroke, chronic renal disease etc which are known to affect the
coagulation system.
Patients on chronic anti platelet or anticoagulant therapy.
Patients on OCPs.
Patients with other hematological disorders.
Also excluded will be patients who have had massive blood loss and transfusion,
prolonged preoperative immobility, patients requiring mechanical ventilation and
prolonged immobilization post operatively.
Post operative re exploration.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the temporal trends in Coagulation profile over time in the perioperative period in patients with Supratentorial Primary Brain tumors using TEGTimepoint: Pre operatively, 24 hours, 48 hours, 72 hours post operaively
- Secondary Outcome Measures
Name Time Method To identify the presence of any specific patterns of Coagulation abnormality in patients with Supratentorial Brain tumors in the perioperative period.Timepoint: Pre operatively, 24 hours, 48 hours, 72 hours post operaively